Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Segway use in individuals with multiple sclerosis.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Cyclophosphamide for multiple sclerosis.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
A touch of MS: Therapeutic mislabeling.
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.

Pages